Home Institutions Cleveland Clinic clinical trials Institution Directory
Clinical trials at Cleveland Clinic Sites in Cleveland, OH
Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.
ClinicalTrials.gov public records Last synced Oct 31, 2026, 3:43 AM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
1320
Current sort
Recently updated
Campus scope
Cleveland Clinic, Cleveland, OH
Additional filters apply within this campus.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Showing 733–744 of 1,320 matching trials with a site at Cleveland Clinic, Cleveland, OH.
Live ClinicalTrials.gov results.
Local aggregate panels are unavailable or hidden for filtered views. The result list above identifies its data source.
Live official records
Conditions Carotid Artery Calcification, Carotid Artery Diseases
Interventions Carotid Intravascular Lithotripsy Device
Lead sponsor Shockwave Medical, Inc. Industry
Eligibility 18 Years and older
Enrollment 185 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2032
U.S. locations 25
States / cities Scottsdale, Arizona • Aurora, Colorado • Jacksonville, Florida + 19 more
Conditions Cardiovascular Diseases, Heart Failure, Ischemic Heart Disease, Non-ischemic Cardiomyopathy, Valvular Heart Disease, Metabolic Cardiomyopathy, Congenital Heart Disease, Aortic Diseases, Atrial Fibrillation, Ventricular Fibrillation
Interventions Not listed
Lead sponsor The Cleveland Clinic Other
Eligibility 18 Years and older
Enrollment 1,000 participants
Healthy volunteers Accepts healthy volunteers
Timeline 2026 – 2037
U.S. locations 1
States / cities Cleveland, Ohio
Conditions Hypertrophic Cardiomyopathy
Interventions EDG-7500 Drug
Lead sponsor Edgewise Therapeutics, Inc. Industry
Eligibility 18 Years and older
Enrollment 79 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2027
U.S. locations 21
States / cities San Francisco, California • Stanford, California • Atlanta, Georgia + 16 more
Conditions Chronic Obstructive Pulmonary Disease (COPD)
Interventions Air cleaner, Sham air cleaner Device
Lead sponsor JHSPH Center for Clinical Trials Other
Eligibility 40 Years and older
Enrollment 770 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2029
U.S. locations 11
States / cities Birmingham, Alabama • Los Angeles, California • Iowa City, Iowa + 7 more
Conditions Acute Respiratory Distress Syndrome (ARDS), ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome
Interventions Cohort A: vilobelimab, Cohort A: placebo Drug
Lead sponsor PPD Development, LP Industry
Eligibility 18 Years and older
Enrollment 200 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2028
U.S. locations 41
States / cities Birmingham, Alabama • Fresno, California • Long Beach, California + 34 more
Conditions Cardiovascular Diseases, Cardiovascular Risk Factors
Interventions Not listed
Lead sponsor University of Oxford Other
Eligibility 18 Years to 99 Years
Enrollment 250,000 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2016 – 2030
U.S. locations 12
States / cities Phoenix, Arizona • New Haven, Connecticut • Tampa, Florida + 8 more
Conditions Metastatic Colorectal Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Colorectal Cancer AJCC v7, Stage IV Lung Non-Small Cell Cancer AJCC v7, Stage IVA Colorectal Cancer AJCC v7, Stage IVB Colorectal Cancer AJCC v7
Interventions Durvalumab, Radiation Therapy, Tremelimumab Biological · Radiation
Lead sponsor National Cancer Institute (NCI) NIH
Eligibility 18 Years and older
Enrollment 110 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2017 – 2027
U.S. locations 41
States / cities Phoenix, Arizona • Scottsdale, Arizona • Los Angeles, California + 29 more
Conditions Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD), EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD), EBV+ Posttransplant Lymphoproliferative Disease in Central Nervous System (EBV+ CNS PTLD), EBV+ Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders, Allogeneic Hematopoietic Cell Transplant, Stem Cell Transplant Complications, EBV+ Sarcomas, Leiomyosarcoma
Interventions Tabelecleucel Biological
Lead sponsor Pierre Fabre Medicament Industry
Eligibility Not listed
Enrollment 190 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2021 – 2028
U.S. locations 23
States / cities Los Angeles, California • Orange, California • Palo Alto, California + 18 more
Conditions Acute Respiratory Distress Syndrome (ARDS), ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome
Interventions Cohort A: vilobelimab, Cohort A: placebo, Cohort B: paridiprubart, Cohort B: placebo, Cohort C: bevacizumab, Cohort C: placebo Drug
Lead sponsor PPD Development, LP Industry
Eligibility 18 Years and older
Enrollment 600 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2028
U.S. locations 41
States / cities Birmingham, Alabama • Fresno, California • Long Beach, California + 34 more
Conditions Acute Respiratory Distress Syndrome (ARDS), ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome
Interventions Cohort C: bevacizumab, Cohort C: placebo Drug
Lead sponsor PPD Development, LP Industry
Eligibility 18 Years and older
Enrollment 200 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2028
U.S. locations 41
States / cities Birmingham, Alabama • Fresno, California • Long Beach, California + 34 more
Conditions Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type, Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type
Interventions Autologous Bone Marrow Transplantation, Autologous Hematopoietic Stem Cell Transplantation, Carmustine, Cyclophosphamide, Cytarabine, Etoposide, Ibrutinib, Laboratory Biomarker Analysis, Melphalan, Pharmacogenomic Study, Placebo Administration Procedure · Drug · Other
Lead sponsor National Cancer Institute (NCI) NIH
Eligibility 18 Years and older
Enrollment 94 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2016 – 2026
U.S. locations 280
States / cities Anchorage, Alaska • Fairbanks, Alaska • Tucson, Arizona + 202 more
Conditions Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Non-Alcoholic Fatty Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Liver Fibrosis, Obesity
Interventions Metabolic surgery, Incretin-Based Therapy Procedure · Drug
Lead sponsor The Cleveland Clinic Other
Eligibility 18 Years to 75 Years
Enrollment 120 participants
Healthy volunteers Accepts healthy volunteers
Timeline 2024 – 2029
U.S. locations 4
States / cities Phoenix, Arizona • Indianapolis, Indiana • Rochester, Minnesota + 1 more About this Cleveland Clinic institution page
What this page lists ClinicalTrials.gov records that list Cleveland Clinic in Cleveland, OH as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.
Related: all institution pages , browse by condition , or browse by U.S. city .